[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples